SAFETY AND EFFICACY OF ESMOLOL (ASL-8052 - AN ULTRASHORT-ACTING BETA-ADRENERGIC BLOCKING-AGENT) FOR CONTROL OF VENTRICULAR RATE IN SUPRAVENTRICULAR TACHYCARDIAS

被引：48

作者：

BYRD, RC

SUNG, RJ

MARKS, J

PARMLEY, WW

机构：

[1] SAN FRANCISCO GEN HOSP,MED CTR,MED SERV,DIV CARDIOL,SAN FRANCISCO,CA 94110

[2] UNIV CALIF SAN FRANCISCO,DEPT MED,DIV CARDIOL,SAN FRANCISCO,CA 94143

[3] UNIV CALIF SAN FRANCISCO,CARDIOVASC RES INST,SAN FRANCISCO,CA 94143

来源：

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 1984年 / 3卷 / 02期

关键词：

D O I：

10.1016/S0735-1097(84)80025-X

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：394 / 399

页数：6

相关论文

共 11 条

[1] AHLQUIST RP, 1977, AM HEART J, V93, P117
[2] ELECTROPHYSIOLOGIC EFFECTS OF INTRAVENOUS PROPRANOLOL IN THE WOLFF-PARKINSON-WHITE SYNDROME
BARRETT, PA
JORDAN, JL
MANDEL, WJ
YAMAGUCHI, I
LAKS, MM
[J]. AMERICAN HEART JOURNAL, 1979, 98 (02) : 213 - 224
[3] EFFECTS OF PROPRANOLOL ON ANOMALOUS PATHWAY REFRACTORINESS AND CIRCUS MOVEMENT TACHYCARDIAS IN PATIENTS WITH PREEXCITATION
DENES, P
CUMMINGS, JM
SIMPSON, R
WU, D
AMATYLEON, F
DHINGRA, R
ROSEN, KM
[J]. AMERICAN JOURNAL OF CARDIOLOGY, 1978, 41 (06) : 1061 - 1067
[4] FITZ GERALD JD, 1969, CLIN PHARMACOL THER, V10, P292
[5] CLINICAL PHARMACOLOGY OF THE NEW BETA-ADRENERGIC BLOCKING-DRUGS .3. COMPARATIVE CLINICAL-EXPERIENCE AND NEW THERAPEUTIC APPLICATIONS
FRISHMAN, W
SILVERMAN, R
[J]. AMERICAN HEART JOURNAL, 1979, 98 (01) : 119 - 131
[6] PHARMACOLOGY OF ASL-8052, A NOVEL BETA-ADRENERGIC-RECEPTOR ANTAGONIST WITH AN ULTRASHORT DURATION OF ACTION
GORCZYNSKI, RJ
SHAFFER, JE
LEE, RJ
[J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1983, 5 (04) : 668 - 677
[7] MURTHY VS, EUR J PHARM
[8] PAULOS M, 1983, CLIN RES, V31, pA212
[9] SUM CY, 1982, 33RD P NAT M AC PHAR
[10] ESMOLOL - A PHARMACOKINETIC PROFILE OF A NEW CARDIOSELECTIVE BETA-BLOCKING AGENT
YACOBI, A
KARTZINEL, R
LAI, CM
SUM, CY
[J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1983, 72 (06) : 710 - 711